Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Is a |
Salicylic acid product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Is a |
Salicylic acid gel |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent kératolytique |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Salicylic acid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Is a |
Product containing heparinoid (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Is a |
Salicylic acid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Heparinoid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent topique |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has manufactured dose form |
Gel (basic dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Is a |
Product containing salicylic acid in topical dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has manufactured dose form |
Conventional release cutaneous gel (dose form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has precise active ingredient |
Heparinoid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
Heparinoid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has concentration strength numerator value |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has precise active ingredient |
Salicylic acid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
Salicylic acid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has concentration strength numerator value |
20 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Is a |
Heparinoid and salicylic acid only product in cutaneous dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Plays role |
Antifungal therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has precise active ingredient |
Heparinoid |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
Heparinoid |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has precise active ingredient |
Salicylic acid (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
Salicylic acid (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Heparinoid 2 mg/g and salicylic acid 20 mg/g cutaneous gel |
Plays role |
Antivaricose therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|